Jun Pan
Impact in
- Rheumatology top 10%
- Osteoarthritis Treatment and Mechanisms
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
Papers in
-
- Natural product bioactivities and synthesis 5
- Biological Activity of Diterpenoids and Biflavonoids 3
- Fibroblast Growth Factor Research 3
- Ubiquitin and proteasome pathways 1
-
- Cancer-related molecular mechanisms research 3
- NF-κB Signaling Pathways 2
- Co-authors
- Lin Zeng (7 shared papers)Dengying Wu (7 shared papers)Tianlong Pan (4 shared papers)Hongwei Lü (5 shared papers)Lipeng Huang (2 shared papers)Chao Jia (3 shared papers)Xiucui Li (3 shared papers)Weiyang Yu (1 shared paper)
- Journals
- International Immunopharmacology (3 papers)Heliyon (2 papers)Cell Death and Disease (2 papers)Cancer Genomics & Proteomics (1 paper)Cell Proliferation (1 paper)
- Partner nations
- ChinaUnited StatesNetherlands
In The Last Decade
Jun Pan
24 papers receiving 542 citations
Peers
Comparison fields: 5 of 88
- Rheumatology 106
- Cancer Research 93
- Geriatrics and Gerontology 17
- Pharmacology 62
- Biochemistry 21
Countries citing papers authored by Jun Pan
This map shows the geographic impact of Jun Pan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jun Pan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jun Pan more than expected).
Fields of papers citing papers by Jun Pan
This network shows the impact of papers produced by Jun Pan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jun Pan. The network helps show where Jun Pan may publish in the future.
Co-authors
The 25 scholars most cited alongside Jun Pan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 88 | |
| 2 | 2017 | 56 | |
| 3 | 2020 | 55 | |
| 4 | 2018 | 52 | |
| 5 | 2019 | 42 | |
| 6 | 2017 | 37 | |
| 7 | 2017 | 36 | |
| 8 | 2019 | 32 | |
| 9 | 2021 | 22 | |
| 10 | 2024 | 20 | |
| 11 | 2022 | 17 | |
| 12 | 2022 | 13 | |
| 13 | 2018 | 13 | |
| 14 | 2007 | 12 | |
| 15 | 2004 | 12 | |
| 16 | 2016 | 10 | |
| 17 | 2024 | 8 | |
| 18 | 2024 | 6 | |
| 19 | 2019 | 4 | |
| 20 | [Effects of chronic hypoxia on the expression of calmodulin and calcicum/calmodulin-dependent protein kinase II and the calcium activity in myocardial cells in young rats]. | 2008 | 4 |
About Jun Pan
Jun Pan is a scholar working on Molecular Biology, Cancer Research, Rheumatology, Plant Science and Immunology, having authored 24 papers that have together received 545 indexed citations. Recurring topics across this work include Natural product bioactivities and synthesis (5 papers), Osteoarthritis Treatment and Mechanisms (3 papers), Biological Activity of Diterpenoids and Biflavonoids (3 papers), Fibroblast Growth Factor Research (3 papers), Cancer-related molecular mechanisms research (3 papers), NF-κB Signaling Pathways (2 papers), Bioactive Compounds in Plants (2 papers) and Ubiquitin and proteasome pathways (1 paper). The work is most often cited by research in Rheumatology (106 citations), Cancer Research (93 citations), Geriatrics and Gerontology (17 citations), Pharmacology (62 citations) and Biochemistry (21 citations). Jun Pan has collaborated with scholars based in China, United States and Netherlands. Frequent co-authors include Lin Zeng, Dengying Wu, Tianlong Pan, Hongwei Lü, Lipeng Huang, Chao Jia, Xiucui Li, Weiyang Yu, Jingdong Zhang and Rong Chen. Their work appears in journals such as International Immunopharmacology, Heliyon, Cell Death and Disease, Cancer Genomics & Proteomics and Cell Proliferation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.